Balanced Rock Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Balanced Rock Investment Advisors's AMGN Position: Q2 2026 in Review
Balanced Rock Investment Advisors reduced its Amgen (AMGN) stake by 1.1% in Q2 2026, selling an estimated $2.4K and leaving 620 shares worth $225K. The position accounts for 0.14% of the portfolio, ranked #93.
Balanced Rock Investment Advisors first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $548K in Q4 2023. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Balanced Rock Investment Advisors held 620 shares of Amgen worth $225K as of Q2 2026.
- Balanced Rock Investment Advisors sold 7 Amgen shares in Q2 2026, an estimated $2.4K.
- Amgen made up 0.14% of Balanced Rock Investment Advisors's portfolio in Q2 2026, its #93 holding.
- Balanced Rock Investment Advisors first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
- Balanced Rock Investment Advisors's Amgen position peaked at $548K in Q4 2023.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Balanced Rock Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.